Wow, wow. So it’s been over two months and I have definitely found a stock that fit the metrics of an undervalued dividend stock investment. It took some thorough research and thinking about the companies that many people take part in every single day or have made them a part of their lives. With healthcare and prescriptions, this led me to this stock and this company shows high signs of undervaluation. Come check out what company I purchased stock into and why!
Over the past few days, I stumbled on an interesting stock that I wanted to share with the community. While I haven’t shared this habit of mine with the dividend investing community in a long time, I have always monitored spin-offs to try to find potential new dividend stocks that are getting ready to (or have recently) hit the market. This strategy has worked well for me in the past, as I stumbled on the fact that Kraft was going to be a dividend paying stock and was lucky enough to catch the company prior to their build up (which occurred long before the announced Heinz-Merger). So why am I bringing this up? Well, beginning July 1, a dividend focused spin-off is getting ready to hit the open market and man has it caught my attention. I wanted to take some time to introduce you to the newly formed Edgewell Personal Care Company.
I had a long conversation with Bert today on the phone as he was on his way to Detroit. It was regarding what the heck to do with my idle cash that I typically use for investment purposes, but am getting anxious as it has been almost two weeks since purchasing a stock. We were trying to discuss if and why I should make extra payments towards my mortgage, which I typically do once per year. Here is how our discussion went.
About a month ago we published our first formal Watch List. A lot has changed over the last month. We have received a ton of dividends, the S&P 500 has increased another .5%, Alibaba began trading, and McDonalds announced a 5% dividend increase! With September nearly in the rear-view mirror, it is time to update our watch list for the end of September and first half of October.
Pharmaceutical. You have to love that industry right? I know the industry has many players, but also many big time pharm teams out there. You have Pfizer, Eli Lilly, Merck, Novartis, GlaxoSmithKline – the list is big and these companies are strong. I bought a dividend stock on September 8th to add to my position for pharmaceutical companies, that company is, GlaxoSmithKline. Continue reading